MonkeyPox Vaccine Has HIGHER Rates of Heart Disease Side Effects than COVID Vaccines and the CDC Wants to Inject them Into Your Children by Brian Shilhavy, Editor, Health Impact News
Now that all age groups for children starting with babies 6 months old have been approved to be injected with the deadly COVID-19 vaccines, the CDC announced last week that they also want to start injecting children with a monkeypox vaccine. Time reports:
U.S. health officials are looking to expand use of the monkeypox vaccine for children as the outbreak continues to spread across the U.S. and in countries around the world, with more than 3,300 cases reported globally.
The U.S. Centers for Disease Control and Prevention is developing a protocol aimed at allowing use of Bavarian Nordic A/S’s Jynneos vaccine in children, if needed, according to documents prepared for a meeting of agency advisers that took place this week. The vaccine is currently cleared for use in adults and is considered safer than Emergent BioSolutions Inc.’s ACAM2000 smallpox vaccine, which can also be used against monkeypox. (Source.)
These are untested vaccines, and the rate of heart disease as a side effect, such as myocarditis, is even higher than the COVID-19 experimental vaccines.
Here is what the CDC currently states regarding the rate of myocarditis and pericarditis after COVID-19 vaccination:
Over 350 million mRNA vaccines were given during the study period and CDC scientists found that rates of myocarditis were highest following the second dose of an mRNA vaccine among males in the following age groups:
- 12–15 years (70.7 cases per one million doses of Pfizer-BioNTech)
- 16–17 years (105.9 cases per one million doses of Pfizer-BioNTech)
- 18–24 years (52.4 cases and 56.3 cases per million doses of Pfizer-BioNTech and Moderna, respectively)
Of course, the CDC is lying, and we have shown this using their own data from the Vaccine Adverse Events Reporting System (VAERS) which reveals much higher rates of heart disease among young people than they are claiming.
The two current vaccines approved for smallpox/monkeypox, however, have even higher rates of myocarditis.
The CDC admits that the ACAM2000 smallpox vaccine has a rate of 5.7 cases of myocarditis per 1,000 doses administered.
That’s 5,700 cases of myocarditis per one million doses!
The monkeypox vaccine they want to inject into children, Jynneos, according to the CDC’s Dr. Brent Petersen, has zero cases of myocarditis.